|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 417.5 TWD | -1.18% |
|
+10.45% | +118.30% |
Caliway Biopharmaceuticals Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 38.93 million compared to TWD 12.82 million a year ago. Net loss was TWD 488.46 million compared to TWD 286.16 million a year ago.
Basic loss per share from continuing operations was TWD 3.94 compared to TWD 2.44 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +118.30% | 1.82B | |
| +38.30% | 723B | |
| +34.28% | 595B | |
| -4.33% | 369B | |
| +20.19% | 332B | |
| +2.99% | 282B | |
| +17.02% | 244B | |
| +9.31% | 208B | |
| -5.07% | 205B | |
| -0.16% | 168B |
CALIWAY BIOPHARMACEUTICALS CO., LTD. 
